It is uncertain what impact President Trump's nomination of Judge Brett Kavanaugh to become the next US Supreme Court justice will have on the biopharmaceutical industry as pharma-related cases that go before the high court do not usually fall along ideological lines.
However, some of Kavanaugh's decisions during his 12 years on the US Court of Appeals for the District of Columbia...





